Effects of Recombinant Human Erythropoietin on Mandibular Distraction Osteogenesis

Journal of Oral and Maxillofacial Surgery

Volumn 67, Issue 11, 2009, Pages 2337-2343

  Mihmanli, Ahmet ^a   Dolanmaz, Dogan ^a   Avunduk, Mustafa C ^a   Erdemli, Esra ^b  

^a SELCUK UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; ISOTONIC SOLUTION; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BONE REGENERATION; CONTROLLED STUDY; DISTRACTION OSTEOGENESIS; FIBROBLAST; MALE; MANDIBLE; MORPHOMETRICS; NONHUMAN; OSTEOBLAST;

ANIMALS; BONE REGENERATION; ERYTHROPOIETIN; HUMANS; MALE; MANDIBLE; OSTEOCLASTS; OSTEOGENESIS, DISTRACTION; RABBITS; RANDOM ALLOCATION; RECOMBINANT PROTEINS; STATISTICS, NONPARAMETRIC; WOUND HEALING;

EID: 70349869040     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2008.06.082     Document Type: Article

References (24)

1. Terheyden H., Wang H., Warnke P.H., et al. Acceleration of callus maturation using rhOP-1 in mandibular distraction osteogenesis in a rat model. Int J Oral Maxillofac Surg 32 (2003) 528
2. Clark C.L., Strider J., Hall C., et al. Distraction osteogenesis in irradiated rabbit mandibles with adjunctive hyperbaric oxygen therapy. J Oral Maxillofac Surg 64 (2006) 589
3. Kitoh H., Kitakoji T., Tsuchiya H., et al. Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis-A preliminary result of three cases. Bone 35 (2004) 892
4. Little D.G., Comell M.S., Briody J., et al. Intravenous pamidronate reduces osteoporosis and improves formation of the regenerate during distraction osteogenesis. A study in immature rabbits. J Bone Joint Surg [Br] 83 (2001) 1069
5. Pampu A.A., Dolanmaz D., Tuz H.H., et al. Experimental evaluation of the effects of zoledronic acid on regenerate bone formation and osteoporosis in mandibular distraction osteogenesis. J Oral Maxillofac Surg 64 (2006) 1232
6. Okazaki H., Kurokawa T., Nakamura K., et al. Stimulation of bone formation by recombinant fibroblast growth factor-2 in callotasis bone lengthening of rabbits. Calcif Tissue Int 64 (1999) 542
7. Raschke M.J., Bail H., Windhagen H.J., et al. Recombinant growth hormone accelerates bone regenerate consolidation in distraction osteogenesis. Bone 24 (1999) 81
8. Sato W., Matsushita T., and Nakamura K. Acceleration of increase in bone mineral content by low-intensity ultrasound energy in leg lengthening. J Ultrasound Med 18 (1999) 699
9. Hagino T., and Hamada Y. Accelerating bone formation and earlier healing after using demineralized bone matrix for limb lengthening in rabbits. J Orthop Res 17 (1999) 232
10. Al Ruhaimi K.A. Effect of calcium sulphate on the rate of osteogenesis in distracted bone. Int J Oral Maxillofac Surg 30 (2001) 228
11. Danis A. Mechanism of bone lengthening by the Ilizarov technique. Bull Mem Acad R Med Belg 156 (2001) 107
12. Miloro M., Miller J.J., and Stoner J.A. Low-level laser effect on mandibular distraction osteogenesis. J Oral Maxillofac Surg 65 (2007) 168
13. Kendall R.G. Erythropoietin. Clin Lab Haematol 23 (2001) 71
14. Buemi M., Vaccaro M., Sturiale A., et al. Recombinant human erythropoietin influences revascularization and healing in a rat model of random ischaemic flaps. Acta Derm Venereol (Stockh) 82 (2002) 411
15. Galeano M., Altavilla D., Cucinotta D., et al. Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes 53 (2004) 2509
16. Haroon Z.A., Amin K., Jiang X., et al. A novel role for erythropoietin during fibrin-induced wound-healing response. Am J Pathol 163 (2003) 993
17. Buemi M., Galeano M., Sturiale A., et al. Recombinant human erythropoietin stimulates angiogenesis and healing of ischemic skin wounds. Shock 22 (2004) 169
18. Mancini D.M., Katz S.D., Lang C.C., et al. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 21 (2003) 294
19. Fearon J.A., and Weinthal J. The use of recombinant erythropoietin in the reduction of blood transfusion rates in craniosynostosis repair in infants and children. Plast Reconstr Surg 109 (2002) 2190
20. McDougall I.C., Cavill I., Davies M.E., et al. Subcutaneous recombinant erythropoietin in the treatment of renal anaemia in CAPD patients. Contrib Nephrol 76 (1989) 219
21. McMahon F.G., Vargas R., Ryan M., et al. Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers. Blood 76 (1990) 718
22. Brown A.L., Tucker B., Baker L.R.I., et al. Seizures related to blood transfusion and erythropoietin treatment in patients undergoing dialysis. Br Med J [Clin Res] 299 (1989) 1258
23. Okazaki H., Kurokawa T., Nakamura K., et al. Stimulation of bone formation by recombinant fibroblast growth factor-2 in callotasis bone lengthening of rabbits. Calcif Tissue Int 64 (1999) 542
24. Little D.G., Smith N.C., Williams P.R., et al. Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis. J Bone Miner Res 18 (2003) 1300